Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2009
11/11/2009EP2116538A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
11/11/2009EP2114917A2 Pyrrole compounds
11/11/2009EP2114900A1 Thiopyrimidine-based compounds and uses thereof
11/11/2009EP2007753B1 Heterocyclic gaba alpha subtype selective receptor modulators
11/11/2009EP1841770B1 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/11/2009EP1833816B1 Substituted piperidines as renin inhibitors
11/11/2009EP1713823B1 Hcv ns-3 serine protease inhibitors
11/11/2009EP1575964B1 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists
11/11/2009EP1492487B1 Mitotic kinesin inhibitors
11/11/2009EP1477186B1 Antipruritics
11/11/2009CN101578282A Furazane derivatives, preparation thereof and energetic compositions containing them
11/11/2009CN101578280A Benzoquinazole derivatives
11/11/2009CN101578277A 5-substituted isoindoline compounds
11/11/2009CN101578272A 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
11/11/2009CN100558728C Calcitonin gene related peptide receptor antagonists
11/11/2009CN100558725C Quinazoline derivatives as antiproliferative agents
11/11/2009CN100558724C Sulphonic acid amide for regulating bast peptide activity and derivative thereof
11/11/2009CN100558713C Pyridazine derivatives and their use as therapeutic agents
11/11/2009CN100558697C Cycloalkyl inhibitors of potassium channel function
11/11/2009CN100558428C Calcitonin gene related peptide receptor antagonists
11/10/2009US7615634 intermediate for synthesis an enzyme inhibitor of cyclin-dependent kinases, having antiproliferative activity and are useful in the treatment or control of cancer, in particular solid tumors
11/10/2009US7615563 Compositions useful as inhibitors of voltage-gated sodium channels
11/10/2009US7615562 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents
11/10/2009US7615555 Piperidine derivatives as modulators of chemokine receptor CCR5
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615552 Fused heterocyclic compounds
11/10/2009US7615551 (8-{4-[3-(5 -Fluoro-1H-indol-3-yl)-propyl]-piperazin-1-yl}-2-methyl-4H-benzo[1,4]oxazin-3-one), for example; useful as modulator of one or more G-protein coupled receptors; for treating or lessening the severity of disorders selected from Parkinson's disease, psychoses depression, anxiety
11/10/2009CA2416785C Novel arylethene-sulfonamides
11/10/2009CA2382117C 4-substituted piperidine compound
11/10/2009CA2353460C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
11/05/2009WO2009134658A2 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
11/05/2009WO2009134400A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009WO2009134392A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009WO2009134387A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009WO2009134384A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009WO2009133970A1 Crystalline compound
11/05/2009WO2009133861A1 Cyclic amine compound
11/05/2009WO2009133831A1 Phenylpropionic acid derivative and use thereof
11/05/2009WO2009133387A1 Indole- 3 -glyoxylamide derivatives for use as calcium ion channel modulators
11/05/2009WO2009133348A1 Aminopyridine derivatives
11/05/2009WO2009133136A1 Compounds
11/05/2009WO2009132453A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009US20090275751 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
11/05/2009US20090275624 Inhibitors of cdc phosphatases
11/05/2009US20090275621 peroxisome proliferator-activated receptors (PPAR) modulators such as 5-(4-{2-[5-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-4-yl]-ethoxy}-phenyl)-3H-[1,3,4]oxadiazol-2-one, used for the treatment of demyelinating diseases and disorders of fatty acid metabolism and glucose utilization
11/05/2009US20090275609 Carboxamide Compounds and Methods for Using The Same
11/05/2009US20090275594 3-hydrazone piperazinyl rifamycin derivatives useful as antimicrobial agents
11/05/2009US20090275581 Renin inhibitors
11/05/2009US20090275580 3-spiroindolin-2-one derivatives, preparation and therapeutic use thereof
11/05/2009US20090275579 3-spiroindolin-2-one derivatives, preparation and therapeutic use thereof
11/05/2009US20090275578 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
11/05/2009US20090275575 Benzophenone derivatives useful for inhibiting formation of microtubule
11/05/2009US20090275571 Morpholinyl and pyrrolidinyl analogs
11/05/2009US20090275569 Benzotriazine Inhibitors of Kinases
11/05/2009US20090275568 Fused quinoline derivative and use thereof
11/05/2009US20090275567 2-heterocycloamino-4-imidazolylpyrimidines as agents for the inhibition of cell proliferation
11/05/2009US20090275565 Substituted aralkyl derivatives
11/05/2009US20090275564 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
11/05/2009US20090275561 Compounds for the Treatment of Hepatitis C
11/05/2009US20090275556 Aryl sulfonamides useful as inhibitors of chemokine receptor activity
11/05/2009US20090275550 2-(4-isopropenylphenyl)-N-[(1R)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide; epilepsy, pain, neuropathic pain, schizophrenia, Parkinson's disease, depression, anxiety, sleep disorders, psychosis, schizophrenia, cardiac arrhythmia and hypertension
11/05/2009US20090275535 Antiviral phosphonate analogs
11/05/2009US20090275533 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
11/05/2009US20090274753 Ph-sensitive polymeric micelles for drug delivery
11/05/2009US20090274656 Hepatitis c virus inhibitors
11/05/2009US20090274655 2-carboxy thiophene derivatives as anti viral agents
11/05/2009US20090274652 Hepatitis C Virus Inhibitors
11/05/2009US20090274650 Inhibitors of aspartyl protease
11/05/2009US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
11/05/2009CA2723039A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009CA2723034A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009CA2723032A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009CA2722704A1 Cyclylamine derivatives as calcium channel blockers
11/05/2009CA2722648A1 Aminopyridine derivatives
11/05/2009CA2722427A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/05/2009CA2722220A1 Fused bicyclic pyrimidine compounds as aurora kinase inhibitors
11/04/2009EP2112880A2 Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment
11/04/2009EP1979345B1 Novel pyridine derivatives
11/04/2009EP1720868B1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
11/04/2009EP1651642B1 Pna monomer and precursor
11/04/2009EP1641465B1 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
11/04/2009EP1499311B1 Substituted benzazoles and use thereof as raf kinase inhibitors
11/04/2009CN101573346A Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
11/04/2009CN101573339A Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and processes for their preparation
11/04/2009CN101573336A Chemical compounds
11/03/2009US7612201 Pyrazole compounds
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612090 Use in treatment of a disorder which is created by or is dependent upon decreased availability of serotonin, norepinephrine or dopamine
11/03/2009US7612075 Anticaogulants; cardiovascular disorders
11/03/2009US7612070 Indole derivative having heterocycle and mono- or diazaindole derivative
11/03/2009US7612068 (S)-1-{2-[2-(4-Fluoro-phenylsulfanyl)-phenoxy]-ethyl}-pyrrolidine-2-carboxylic acid; glycine transport inhibitors; for schizophrenia and other psychoses
11/03/2009US7612067 Imidazopyridazine compounds
11/03/2009US7612065 Fused n-heterocylic derivatives; mitogen-activated protein kinase inhibitors; Parkinson's disease
11/03/2009US7612064 Sulfopyrroles
11/03/2009US7612060 (R)-3-((1-((R)-7-cyclopropylaminomethyl-3,4-dihydro-2H-chromen-4-yl)-1H-1,2,3-triazol-4-yl)methyl)-4-(4-methylbenzenesulfonyl)-3,4-dihydropyrazin-2(1H)-one; pain, inflammation
11/03/2009US7612059 Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
11/03/2009US7612054 Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
11/03/2009CA2474510C Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/03/2009CA2449729C Prodrugs of gaba analogs, compositions and uses thereof
11/03/2009CA2443724C Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
1 ... 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 ... 647